
Mark A. Munger, PharmD
Advertisement
Articles by Mark A. Munger, PharmD

Advertisement
Latest Updated Articles
Critical Overview of Antihypertensive Therapies: What is Preventing Us from Getting There?Published: March 1st 2000 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
3
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
4
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
5



